Stock Earnings
Recent Insider Activity Could Benefit G1 Therapeutics Inc (GTHX)
G1 Therapeutics Inc’s filing revealed that its Chief Financial Officer Umstead John W. V unloaded Company’s shares for reported $19752.0
Menu
G1 Therapeutics Inc’s filing revealed that its Chief Financial Officer Umstead John W. V unloaded Company’s shares for reported $19752.0
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
G1 Therapeutics Inc’s recent filing unveils that its Chief Financial Officer Umstead John W. V unloaded Company’s shares for reported
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
In a filing, G1 Therapeutics Inc revealed its Chief Financial Officer Umstead John W. V unloaded Company’s shares for reported
G1 Therapeutics Inc’s recently made public that its Chief Financial Officer Umstead John W. V unloaded Company’s shares for reported